Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 38.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 423,868 shares of the health services provider's stock after selling 262,572 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.25% of Teladoc Health worth $3,853,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Whipplewood Advisors LLC bought a new position in Teladoc Health in the 4th quarter worth approximately $29,000. Lindbrook Capital LLC boosted its position in Teladoc Health by 78.9% during the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider's stock valued at $33,000 after purchasing an additional 1,612 shares in the last quarter. Sterling Capital Management LLC raised its stake in Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider's stock valued at $42,000 after buying an additional 4,101 shares during the last quarter. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Teladoc Health in the fourth quarter worth about $60,000. Finally, Generali Investments Management Co LLC purchased a new position in shares of Teladoc Health in the fourth quarter worth about $64,000. 76.82% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, insider Adam C. Vandervoort sold 5,808 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $39,842.88. Following the transaction, the insider now owns 69,773 shares in the company, valued at $478,642.78. This represents a 7.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Fernando M. Rodrigues sold 4,174 shares of the company's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The disclosure for this sale can be found here. In the last ninety days, insiders sold 29,667 shares of company stock worth $220,901. 0.58% of the stock is currently owned by corporate insiders.

Teladoc Health Stock Performance

Shares of TDOC traded down $0.20 during trading hours on Thursday, hitting $6.93. The company's stock had a trading volume of 5,451,781 shares, compared to its average volume of 6,272,224. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health, Inc. has a 52-week low of $6.35 and a 52-week high of $15.21. The company has a market cap of $1.21 billion, a price-to-earnings ratio of -1.20 and a beta of 1.82. The business has a 50 day simple moving average of $7.18 and a two-hundred day simple moving average of $9.16.

Analyst Ratings Changes

Several analysts have commented on TDOC shares. Truist Financial dropped their price objective on Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a report on Tuesday, May 27th. The Goldman Sachs Group dropped their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Canaccord Genuity Group reduced their target price on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a research report on Thursday, May 1st. Finally, Jefferies Financial Group cut their price target on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Twelve equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, Teladoc Health presently has an average rating of "Hold" and a consensus target price of $9.60.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.